ğŸš¨ **LIVE SIGNAL: $COR strategy triggered entry TODAY**

22.1% annual returns, 2.87 reward/risk ratio - this healthcare giant just flashed a buy signal.
Here's why this signal matters. ğŸ‘‡

âœ… **Strategy Performance ($COR, Daily, 14.7 years)**
â€¢ Win Rate: 45% (75 trades)
â€¢ Net Performance: +373.6%
â€¢ Avg Win/Loss: +9.83% / -3.43%
â€¢ Reward/Risk Ratio: **2.87**
â€¢ Max Drawdown: -42.5% (vs B&H: -40.9%)
â€¢ Sharpe: 0.62 | Sortino: 1.33
â€¢ Exposure: 60.2% | Avg Trade: 29 days
â€¢ Expectancy: $0.70 per $1 risked

ğŸ“… **Seasonality Edge (15 years)**
June timing: **Strong** (67% historical avg)
â€¢ Best months: Aug (73%), Sep (80%) avg performance
â€¢ Worst months: Jul (43%) avg performance
â€¢ Current month (June): 67% historical avg
â€¢ Pattern strength: Strong positive bias across most months

ğŸ” **Why This Signal Triggered TODAY**
â€¢ **Entry Condition**: SMA crossover signal confirmed
â€¢ **Technical Setup**: Bullish ascending triangle (complete)
â€¢ **Fundamental Catalyst**: GLP-1 drug explosion driving 30% of growth
â€¢ **Market Context**: Outperforming SPY since March, defensive healthcare
â€¢ **Risk Management**: Low beta (0.44) with strong seasonality support

ğŸ“Š **$COR Fundamentals**
â€¢ **Price Target**: $325 (10% upside from ~$295)
â€¢ **Key Metrics**: 17.15x forward P/E, 21.31% ROIC
â€¢ **Catalysts**: $4.6B RCA acquisition, specialty pharma transformation

ğŸ“Œ **Bottom Line**
Strategy with 373% historical returns just triggered entry signal. June strong seasonality (67%) + completed triangle + GLP-1 catalyst align for compelling opportunity.

Time to act on this live signal. ğŸ¯

#COR #trading #livesignal #entry #seasonality #SMA #investing
